BJDXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Bluejay Diagnostics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.70−0.05 (-6.46%)
Close on Oct 19, 2026
- Market cap
- $1.45M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Bluejay Diagnostics has not reported a dividend
No dividend per share appears in Bluejay Diagnostics's annual filings since fiscal 2019.